Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Interline Therapeutics on the deal. Interline Therapeutics, a data science and healthcare company, announced its $92 million Series...
Interline Therapeutics’ $92 million Series Seed and Series A financing
Pomelo’s $9 Million Series Seed Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Pomelo on the deal. Pomelo, a startup building a fintech-as-a-service platform for Latin America, has raised $9...
Sanlo’s $3.5 Million Seed Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Sanlo on the deal. Sanlo, a fintech startup, announced its $3.5 million Series Seed financing co-led by Index Ventures...
Bitso’s $250M Series C Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Bitso on the deal. Bitso, a cryptocurrency platform in Latin America, announced its $250 million Series C financing...
Super’s $28M Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Super on the deal. The startup Super announced it has raised an oversubscribed $28 million Series B led...
Warren’s $55.61M Series C Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Warren on the deal. Nelson Mullins acted for Chromo Invest. Warren has consolidated its position among Brazil’s...
Shapeways’ Merger Agreement with Galileo Acquisition Corp.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Shapeways, Inc. on the deal. Shapeways, Inc., a global digital manufacturing platform provider, announced it has entered...
Ukko’s $40 Million Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP and Gross & Co. advised Ukko on the deal. Ukko, a biotech company with the mission to eliminate...